Activated glycoprotein A repetitions predominant (GARP)-expressing regulatory T cells inhibit allergen-induced intestinal inflammation in humanized mice

Journal of Allergy and Clinical Immunology

Volumn 136, Issue 1, 2015, Pages 159-168

  Eschborn, Melanie ^a   Weigmann, Benno ^a   Reissig, Sonja ^b   Waisman, Ari ^b   Saloga, Joachim ^a   Bellinghausen, Iris ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

allergen; colon; Humanized mice; IgE; inflammation; regulatory T cells

Indexed keywords

ALLERGEN; ANTIALLERGIC AGENT; ANTIINFLAMMATORY AGENT; CD4 ANTIGEN; FIBRIN; GLYCOPROTEIN; GLYCOPROTEIN A REPITITIONS PREDOMINANT; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; RECOMBINANT HUMAN GLYCOPROTEIN A REPITITIONS PREDOMINANT; RECOMBINANT PROTEIN; SODIUM CHLORIDE; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; BLOCKING ANTIBODY; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; LRRC32 PROTEIN, HUMAN; MEMBRANE PROTEIN;

ALLERGY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL INFILTRATION; CELL THERAPY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; ENGRAFTMENT; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERFERON GAMMA RELEASE ASSAY; LYMPHOCYTE DEPLETION; LYMPHOCYTE PROLIFERATION; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION; VASCULARIZATION; ANIMAL; BLOOD; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL PROLIFERATION; DISEASE MODEL; DRUG EFFECTS; HYPERSENSITIVITY; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; INTESTINE; METABOLISM; SCID MOUSE; TRANSPLANTATION;

ALLERGENS; ANIMALS; ANTIBODIES, BLOCKING; ANTIBODY FORMATION; ANTIGENS, CD4; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; IMMUNOSUPPRESSION; INFLAMMATION; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTESTINES; LEUKOCYTES, MONONUCLEAR; MALE; MEMBRANE PROTEINS; MICE; MICE, SCID; T-LYMPHOCYTES, REGULATORY;

EID: 84936992228     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2015.04.020     Document Type: Article

References (41)

1. C.A. Akdis Therapies for allergic inflammation: refining strategies to induce tolerance Nat Med 18 2012 736 749
2. A.W. Burks, M.A. Calderon, T. Casale, L. Cox, P. Demoly, M. Jutel, and et al. Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report J Allergy Clin Immunol 131 2013 1288 1296
3. S.H. Sicherer, and D.Y. Leung Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2012 J Allergy Clin Immunol 131 2013 55 66
4. K. Takeda, and E.W. Gelfand Mouse models of allergic diseases Curr Opin Immunol 21 2009 660 665
5. J. Wisniewski, R. Agrawal, and J.A. Woodfolk Mechanisms of tolerance induction in allergic disease: integrating current and emerging concepts Clin Exp Allergy 43 2013 164 176
6. T.H. Nguyen, and T.B. Casale Immune modulation for treatment of allergic disease Immunol Rev 242 2011 258 271
7. S. Wenzel, L. Ford, D. Pearlman, S. Spector, L. Sher, F. Skobieranda, and et al. Dupilumab in persistent asthma with elevated eosinophil levels N Engl J Med 368 2013 2455 2466
8. J. Corren, R.F. Lemanske, N.A. Hanania, P.E. Korenblat, M.V. Parsey, J.R. Arron, and et al. Lebrikizumab treatment in adults with asthma N Engl J Med 365 2011 1088 1098
9. M.A. Brehm, N. Jouvet, D.L. Greiner, and L.D. Shultz Humanized mice for the study of infectious diseases Curr Opin Immunol 25 2013 428 435
10. R. Gagnon, Y. Boutin, and J. Hebert Lol p I-specific IgE and IgG synthesis by peripheral blood mononuclear cells from atopic subjects in SCID mice J Allergy Clin Immunol 95 1995 1268 1275
11. U. Herz, V.A. Botchkarev, R. Paus, and H. Renz Increased airway responsiveness, allergy-type-I skin responses and systemic anaphylaxis in a humanized-severe combined immuno-deficiency mouse model Clin Exp Allergy 34 2004 478 487
12. F. Perros, H.C. Hoogsteden, A.J. Coyle, B.N. Lambrecht, and H. Hammad Blockade of CCR4 in a humanized model of asthma reveals a critical role for DC-derived CCL17 and CCL22 in attracting Th2 cells and inducing airway inflammation Allergy 64 2009 995 1002
13. S.S. Sonar, Y.M. Hsu, M.L. Conrad, G.R. Majeau, A. Kilic, E. Garber, and et al. Antagonism of TIM-1 blocks the development of disease in a humanized mouse model of allergic asthma J Clin Invest 120 2010 2767 2781
14. L.D. Shultz, M.A. Brehm, J.V. Garcia-Martinez, and D.L. Greiner Humanized mice for immune system investigation: progress, promise and challenges Nat Rev Immunol 12 2012 786 798
15. M. King, T. Pearson, L.D. Shultz, J. Leif, R. Bottino, M. Trucco, and et al. A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene Clin Immunol 126 2008 303 314
16. I. Bellinghausen, S. Reuter, H. Martin, J. Maxeiner, U. Luxemburger, O. Tureci, and et al. Enhanced production of CCL18 by tolerogenic dendritic cells is associated with inhibition of allergic airway reactivity J Allergy Clin Immunol 130 2012 1384 1393
17. H. Martin, S. Reuter, N. Dehzad, A. Heinz, I. Bellinghausen, J. Saloga, and et al. CD4-mediated regulatory T-cell activation inhibits the development of disease in a humanized mouse model of allergic airway disease J Allergy Clin Immunol 129 2012 521 528
18. B. Weigmann, N. Schughart, C. Wiebe, S. Sudowe, H.A. Lehr, H. Jonuleit, and et al. Allergen-induced IgE-dependent gut inflammation in a human PBMC-engrafted murine model of allergy J Allergy Clin Immunol 129 2012 1126 1135
19. C. Becker, M.C. Fantini, and M.F. Neurath High resolution colonoscopy in live mice Nat Protoc 1 2006 2900 2904
20. I. Bellinghausen, B. Klostermann, J. Knop, and J. Saloga Human CD4+CD25+ T cells derived from the majority of atopic donors are able to suppress TH1 and TH2 cytokine production J Allergy Clin Immunol 111 2003 862 868
21. I. Bellinghausen, B. König, I. Böttcher, J. Knop, and J. Saloga Regulatory activity of human CD4+CD25+ T cells depends on allergen concentration, type of allergen and atopy status of the donor Immunology 116 2005 103 111
22. H. Grindebacke, K. Wing, A.C. Andersson, E. Suri-Payer, S. Rak, and A. Rudin Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season Clin Exp Allergy 34 2004 1364 1372
23. E.M. Ling, T. Smith, X.D. Nguyen, C. Pridgeon, M. Dallman, J. Arbery, and et al. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease Lancet 363 2004 608 615
24. R. Wang, L. Kozhaya, F. Mercer, A. Khaitan, H. Fujii, and D. Unutmaz Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells Proc Natl Acad Sci U S A 106 2009 13439 13444
25. D.Q. Tran, J. Andersson, R. Wang, H. Ramsey, D. Unutmaz, and E.M. Shevach GARP (LRRC32) is essential for the surface expression of latent TGF-beta on platelets and activated FOXP3+ regulatory T cells Proc Natl Acad Sci U S A 106 2009 13445 13450
26. S.A. Hahn, H.F. Stahl, C. Becker, A. Correll, F.J. Schneider, A. Tuettenberg, and et al. Soluble GARP has potent antiinflammatory and immunomodulatory impact on human CD4(+) T cells Blood 122 2013 1182 1191
27. I. Bellinghausen, B. König, I. Böttcher, J. Knop, and J. Saloga Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction Clin Exp Allergy 36 2006 1546 1555
28. H. Maazi, S. Shirinbak, M. Willart, H.M. Hammad, M. Cabanski, L. Boon, and et al. Contribution of regulatory T cells to alleviation of experimental allergic asthma after specific immunotherapy Clin Exp Allergy 42 2012 1519 1528
29. L. Pellerin, J.A. Jenks, P. Begin, R. Bacchetta, and K.C. Nadeau Regulatory T cells and their roles in immune dysregulation and allergy Immunol Res 58 2014 358 368
30. O.U. Soyer, M. Akdis, J. Ring, H. Behrendt, R. Crameri, R. Lauener, and et al. Mechanisms of peripheral tolerance to allergens Allergy 68 2013 161 170
31. G. Gri, S. Piconese, B. Frossi, V. Manfroi, S. Merluzzi, C. Tripodo, and et al. CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction Immunity 29 2008 771 781
32. M. Pierkes, I. Bellinghausen, T. Hultsch, G. Metz, J. Knop, and J. Saloga Decreased release of histamine and sulfidoleukotrienes by human peripheral blood leukocytes after wasp venom immunotherapy is partially due to induction of IL-10 and IFN-gamma production of T cells J Allergy Clin Immunol 103 1999 326 332
33. R. Kanjarawi, M. Dy, E. Bardel, T. Sparwasser, B. Dubois, S. Mecheri, and et al. Regulatory CD4+Foxp3+ T cells control the severity of anaphylaxis PLoS One 8 2013 e69183
34. H. Groux, A. O'Garra, M. Bigler, M. Rouleau, S. Antonenko, J.E. de Vries, and et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis Nature 389 1997 737 742
35. S. Sakaguchi, T. Yamaguchi, T. Nomura, and M. Ono Regulatory T cells and immune tolerance Cell 133 2008 775 787
36. M. Shale, C. Schiering, and F. Powrie CD4(+) T-cell subsets in intestinal inflammation Immunol Rev 252 2013 164 182
37. G.H. Stummvoll, R.J. DiPaolo, E.N. Huter, T.S. Davidson, D. Glass, J.M. Ward, and et al. Th1, Th2, and Th17 effector T cell-induced autoimmune gastritis differs in pathological pattern and in susceptibility to suppression by regulatory T cells J Immunol 181 2008 1908 1916
38. E.N. Huter, G.H. Stummvoll, R.J. DiPaolo, D.D. Glass, and E.M. Shevach Pre-differentiated Th1 and Th17 effector T cells in autoimmune gastritis: Ag-specific regulatory T cells are more potent suppressors than polyclonal regulatory T cells Int Immunopharmacol 9 2009 540 545
39. C. Becker, C. Taube, T. Bopp, C. Becker, K. Michel, J. Kubach, and et al. Protection from graft-versus-host disease by HIV-1 envelope protein gp120-mediated activation of human CD4+CD25+ regulatory T cells Blood 114 2009 1263 1269
40. H. Nishikawa, and S. Sakaguchi Regulatory T cells in cancer immunotherapy Curr Opin Immunol 27 2014 1 7
41. S. Kalathil, A.A. Lugade, A. Miller, R. Iyer, and Y. Thanavala Higher frequencies of GARP(+)CTLA-4(+)Foxp3(+) T regulatory cells and myeloid-derived suppressor cells in hepatocellular carcinoma patients are associated with impaired T-cell functionality Cancer Res 73 2013 2435 2444